The Ovarian Cancer Research And Information Amendments Of 2001

Mr. Speaker, I rise today to announce that I am today introducing the Ovarian Cancer and Research Amendments of 2001. I am proud to be joined by 56 original co-sponsors and would like to invite the rest of my colleagues to join me in support of the bill.
Ovarian cancer is the most lethal cancer of the female reproductive system, primarily because it is so difficult to detect in its early stages. While survival rates are quite high if the disease is found before it spread beyond the ovaries, the five-year survival rate drops to 28% for women who are diagnosed and treated in the later stages of the disease. Only 25% of ovarian cancer cases are caught in the earliest stages.
The Ovarian Cancer and Research Amendments of 2001 have three components. First, it authorizes $150 million for ovarian cancer research: one- half to be spent on basic cancer research and one-half on clinical trials and treatment. The bill requires that priority be given to developing a test for the early detection of ovarian cancer; research to identify precursor lesions and to determine the manner in which benign conditions progress to malignant status; and research to determine the relationship between ovarian cancer and endometriosis. Moreover, the bill requires that appropriate counseling be provided to women participating in clinical trials.   Second, the bill provides for a comprehensive education program to provide information to patients and the public on screening procedures, the genetic basis to ovarian cancer, factors that increase the risk of getting ovarian cancer; and any new treatments for ovarian cancer.   Finally, it requires that the National Cancer Advisory Board include at least one individual who is at high risk of developing ovarian cancer.  I hope all my colleagues will join me in supporting this worthy cause and help to give women a fighting chance against ovarian cancer.

What is the price of Imatinib in India

REVEALING MY SECRET RESEARCH

It is almost a year since I have come to this ng.  You heard many times how I verify all I hear, read. Not long ago, there was a research done in Europe which said that the most single reason for cancer in human is lack of respect we experience in our lives. Looking at the people whom I knew, looking into my experiences it stroked me as something very probable.

Almost at the same time coincidentally I started to look into Freemasonry. When I started reading this ng there seemed to be lots of disrespect toward ‘cowans’ non masons and others. Not immediately, but after a while I decided on an experiment.  This ng was a perfect environment for it. Will my cancer return or not if I allow myself to feel that disrespect from you?

While my heart went to others I willingly submitted myself. I had times of scare, of pain, the desire to leave sooner but I was convinced there must be more time, at least a year (on average 18 months) of that treatment to see the results. Now at the request and begging from my family and friends I will leave you.  They say it is enough!!! I we all agree with that. I will allow myself to be observed here in Canada for some time before I go to Europe where loving people beg me to come back.

Meanwhile, I have good news.  I bought myself a bright new home and soon will start entirely new life in a new place. I will not read this ng anymore and please do not comment. I know it now that was the most ‘kooky’ idea I have ever had.

 

Cannabis Extract Shrinks Brain Tumors

Cannabis extracts may shrink brain tumours and other cancers by blocking the growth of the blood vessels which feed them, suggests a new study. An active component of the street drug has previously been shown to improve brain tumours in rats. But now Manuel Guzmán at Complutense University, Spain, and colleagues have demonstrated how the cannabis extracts block a key chemical needed for tumours to sprout blood vessels – a process called angiogenesis.

And for the first time, the team has shown the cannabinoids impede this chemical in people with the most aggressive form of brain cancer - glioblastoma multiforme. Cristina Blázquez at Complutense University, and one of the team, stresses the results are preliminary. “But it’s a good point to start and continue,” she told New Scientist. “The cannabinoid inhibits the angiogenesis response - if a tumour doesn’t do angiogenesis, it doesn’t grow,” she explains. “So if you can improve angiogenesis on one side and kill the tumour cells on the other side, you can try for a therapy for cancer.” “This research provides an important new lead compound for anti-cancer drugs targeting cancer’s blood supply,” says Richard Sullivan, head of clinical programmes, at Cancer Research UK.

Fat molecule

The team tested the effects of delta-9-tetrahydrocannabinol in 30 mice. They found the marijuana extract inhibited the expression of several genes related to the production of a chemical called vascular endothelial growth factor (VEGF). VEGF is critical for angiogenesis, which allows tumours to grow a network of blood vessels to supply their growth. The cannabinoid significantly lowered the activity of VEGF in the mice and two human brain cancer patients, the study showed. The drug did this by increasing the activity of a fat molecule called ceramide, suggests the study, as adding a ceramide inhibitor stifled the ability of the cannabinoid to block VEGF.

Small and pallid

“We saw that the tumours [in mice] were smaller and a bit pallid,” adds Blázquez. The paleness of the cancer reflected its lack of blood supply as a result of the treatment. In the human patients, she says: “It seems that it works, but it’s very early.” Sullivan points out: “Although this work is at an early stage of development other research has already demonstrated that VEGF is an important drug target for a range of cancers.” He emphasises the need for further work on cannabinoid combinations. “Cannabinoids would need to generate very strong data in the future as there are already a number of VEGF inhibitors in clinical development,” he says. The two patients in the ongoing study are among 14 in a clinical trial of the drug. The patients are given one cycle of treatment, lasting a few days, and their survival and general health are being studied.

 

Marijuana May Stall Brain Tumor Growth

Researchers say the cannabinoids found in marijuana may aid in brain tumor treatment by targeting the genes needed for the tumors to sprout blood vessels and grow. Their study showed that cannabinoids inhibited genes needed for the production of vascular growth factor (VEGF) in laboratory mice with glioma brain tumors and two patients with late-stage glioblastoma multiforme, a form of brain cancer.

VEGF is a protein that stimulates blood vessels to grow. Tumors need an abundant blood supply because they generally grow rapidly. So when VEGF is blocked, tumors starve from lack of blood supply and nutrients. Blocking of VEGF constitutes one of the most promising tumor-fighting approaches currently available, says researcher Manuel Guzman, professor of biochemistry and molecular biology, at the Complutense University in Madrid, Spain, in a news release.

Guzman says the findings suggest VEGF may be a new target for cannabinoid-based treatments. Previous studies have shown that cannabinoids could inhibit the growth of tumor-associated blood vessels in mice, but until now little was known about how they worked. The results of the study appear in the Aug. 15 issue of the journal Cancer Research. Cannabinoids May Help Starve Tumors

In the study, researchers looked at the effects of cannabinoid treatment on gliobastoma multiforme, a form of brain cancer that affects about 7,000 Americans each year. It’s considered one of the deadliest forms of cancer and usually results in death within one to two years after diagnosis. Treatment typically involves surgery, followed by radiation and/or chemotherapy. But despite these efforts to destroy the tumor, this type of brain tumor often survives and starts growing again, which is why researchers are looking for novel ways to attack it.

In order to grow, all tumors require a network of blood vessels to feed them, and they create this network through a process known as angiogenesis. VEGF is critical to this process. In the first part of the study, researchers induced brain cancer in mice and then treated them with cannabinoids. They then analyzed the genes associated with the growth of blood vessels in the tumor and found that cannabinoids inhibited several of the genes related to VEGF. In the second part of the study, researchers injected cannabinoids into tumor samples taken from two human glioblastoma patients.

“In both patients, VEGF levels in tumor extracts were lower after cannabinoid inoculation,” says Guzman. Researchers say more study is needed but the results suggest that cannabinoid-based therapies may offer a new alternative for treatment of these otherwise untreatable brain tumors.

 

USA Today: “Plant foods to the rescue”

Scientists who study nutrition paint a very different picture.

A growing body of research shows that, once inside the body, fruits and vegetables spring into the role of superheroes, fighting cancer and other diseases in at least eight simultaneous ways. And, like the Superfriends, they seem to work better as a team. Some phytochemicals, or plant chemicals, knock out carcinogens and fight inflammation. Some regulate how quickly cells reproduce and spur old, damaged cells to self-destruct. Other plant chemicals perform “routine maintenance” on DNA, says Jeff Prince, vice president for education at the Washington-based American Institute for Cancer Research.

Doctors caution that recent research indicates that fruits and vegetables may not provide as much protection against cancer as once believed. In the past five years, studies have shown that weight control may be more crucial, says Walt Willett, chairman of the nutrition department at the Harvard School of Public Health.

Yet most experts agree that the body needs a variety of these phytochemicals - there are more than 25,000 of them - to stay in top form. That’s why so many nutritionists no longer stress individual “power foods,” Prince says, but instead promote a “plant-based” diet of fruits, vegetables, whole grains, beans and nuts. Preliminary research indicates these foods bring out the best in each other and magnify their protective effects.

At the cancer institute’s annual scientific conference in July, researchers from the University of Illinois-Urbana described their research feeding tomatoes and broccoli to lab rats that had prostate cancer. The tumors of rats that were fed both vegetables shrank far more than those of animals who ate either food alone. Researchers stressed, though, that people do not necessarily react the same way as animals and that many larger studies need to be done to confirm these results.

“The take-home message is not that experts recommend tomatoes and broccoli,” Prince said at the conference. “We’re not going to find a single source that fights disease. What’s important is the interaction of thousands of plant chemicals.” Humans evolved to depend on a rich diet of 800 plant foods, says David Heber, director of the University of California-Los Angeles Center for Human Nutrition. Today, he says, most people eat three, and those are often french fries, ketchup and iceberg lettuce.

Yet some potentially potent plant foods, experts say, are exotic varieties that Americans rarely sample: herbs such as ginseng; spices such as turmeric, used in Indian cooking; and Reishi and Maitake mushrooms from Japan. Heber suggests that people select their five to nine recommended daily servings of fruits and vegetables from seven color groups, such as purple grapes or yellow squash, whose colors are produced by disease-fighting chemicals called carotenoids.

Scientists have identified only a handful of the thousands of potentially beneficial plant chemicals, says Daniel Nixon, author of The Prostate Health Program and president of the Institute for Cancer Prevention in New York. People who would rather pop dietary supplements instead of eating the real thing may miss out on proven health promoters such as fiber, as well as compounds that scientists have yet to discover, Nixon says. Last week, the American Heart Association published an advisory finding that antioxidant supplements do not prevent heart disease. In some studies, supplements with beta carotene - the chemical that colors carrots orange - increased the risk of cancer.

Plants vs. disease

Plant foods, however, may help prevent a number of diseases, says Rachel Brandeis of the American Dietetic Association. Antioxidants found in vegetables neutralize dangerous molecules called “free radicals,” which are produced by smoking and radiation, as well as everyday activities of the body. Left to themselves, free radicals attack healthy cells and may lead to plaques in the arteries and even Alzheimer’s. They also can damage DNA in ways that lead to cancer. As plants evolved, they developed antioxidants to fight free radicals, Heber says. Humans grew to depend on fruits, vegetables and nuts to provide these vital defenses. That may explain why, without a rich plant diet, people are more vulnerable to disease. Diets rich in plant compounds, on the other hand, may prevent a variety of ailments.

At a meeting of the Alzheimer’s Association last month, for example, researchers presented the results of a six-year study of 3,000 senior citizens. In the study, people who consumed lots of vitamin C and carotenoids, both through food and supplements, scored higher on reasoning tests. Carotenoids are found in squash, strawberries and other fruits. According to another study presented at the meeting, vegetables such as spinach and broccoli - which contain vitamin C and carotenoids, as well as the vitamin folic acid - were found to slow cognitive decline.

Other things that appear to lower the risk of Alzheimer’s include vitamin E, found in wheat germ, and fatty fish, such as salmon and mackerel, which are rich in omega-3 fatty acids, according to the Alzheimer’s Association. Scientists say they still have many questions about antioxidants: Can they fight cancer at any stage of the disease or at any age? Or do people benefit only if they consume these foods from infancy? Under which circumstances might antioxidants promote disease, rather than healing?

Scientists have identified at least a handful of the ways that plant foods appear to fight disease, says Cheryl Rock, a professor of nutrition at the University of California-San Diego Cancer Center. * By mopping up free radicals, antioxidants such as the beta carotene in sweet potatoes or the vitamin E in almonds prevent cell damage. Another class of chemicals called flavonoids have been shown to activate the body’s natural DNA repair system.

* Fruits and vegetables often are high in potassium, which can help control blood pressure.

* Antioxidants may interrupt a process leading to inflammation, which appears to play a role in cardiovascular disease and cancer. Vitamin B6, found in bananas, and folic acid, found in broccoli and leafy greens, both lower levels of homocysteine, which has been linked to hardening of the arteries, heart attacks, strokes and dementia.

* Chemicals such as beta carotene also help regulate the natural cycle of cell birth and death, telling cells when to divide, differentiate into new types or recycle themselves. Keeping this process under tight control can prevent cancer, Rock says.

* Phytochemicals in foods such as Brussels sprouts, red cabbage and kale may help prevent cancer by activating enzymes that break down carcinogens.

Antioxidants vs. angiogenesis

* Emerging research suggests that antioxidants may shut down a process called angiogenesis, by which tumors recruit blood supplies that help them grow and spread, says William Li, president of the Angiogenesis Foundation. Scientists are investigating links between angiogenesis and compounds found in foods such as licorice, blueberries and garlic, Li says.

Researchers who studied tumors in mice were able to cut back the number of new blood vessels by 70% simply by replacing their water with green tea, Li says. Scientists have not proved this link in humans.

* Plant foods such as whole-grain cereals and oats are loaded with fiber. In a study of 40,000 male health professionals, high-fiber diets reduced the risk of coronary heart disease by 40%. Diets filled with cereal fiber also may help prevent diabetes and a painful intestinal inflammation called diverticular disease. “Mother Nature is cleverer than all of us and has laced many of our favorite foods with things that can be helpful,” Li says. “Ancient cultures have long recognized that your diet can be healing, and
scientists are only now beginning to understand why.” Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns - ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins - combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets.

Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins - combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets. Tomatoes The carotenoid lycopene. Eating several servings a week may reduce the risk of prostate cancer up to 35% and also may reduce the risk of heart attack and stroke. To get the most lycopene, cook tomatoes with a little “healthful” fat, such as olive oil.

Whole-grain breads and cereals Fiber and antioxidants. May lower the risk of heart disease by 40%. May also help prevent diabetes. Read labels to make sure that the first ingredient in the bread says whole wheat, not just wheat or “stone-ground wheat.” Salmon, mackeral, sardines Omega-3 fatty acids. Reduces risk of heart disease, diabetes and possibly Alzheimer’s and cancer. Reduces inflammation, which may help prevent or relieve symptoms of arthritis. Contains vitamin D, which builds strong bones and may protect against colon cancer. Cooked, to kill microorganisms and parasites. Broiled, to eliminate contaminants found in freshwater fish. For canned fish, serve with the soft, mashed, calcium-rich bones.

Spinach and other leafy greens Folic acid. This may reduce risk of birth defects, heart attack, Alzheimer’s, depression and inflammation. Folic acid also reduces the risk of fractures. Potassium lowers blood pressure and the danger of strokes. The carotenoids lutein and zeaxanthin may help fight age-related eye disease. Antioxidants called flavones may reduce breast cancer risk.  Fresh or lightly steamed to preserve vitamin C; with nuts, olive oil or avocados, whose fat helps to increase absorption of antioxidants.

Blueberries or other berries Antioxidants such as vitamin C. These may reduce risk of heart disease, cancer, mental decline and other diseases of aging. May help prevent urinary-tract infections by inhibiting bacteria.  Fresh, raw or lightly cooked. Wash them just before serving to avoid mold and bruising. Canning blueberries removes half of the vitamin C. Sweet potatoes Carotenoids, which may help reduce the risk of Alzheimer’s. Beta carotene also may lower the risk of cancers of the larynx, esophagus and lungs. Baked or boiled.

 

Male breast cancers ‘more common’

More men are developing breast cancer - but most fail to spot tumours until they are at an advanced stage, a study has warned. University of Texas research found that, while men are far less likely to develop breast tumours than women, the numbers are increasing. Writing in an online edition of the journal Cancer, they warn men seem to be unaware they can develop the cancer.

UK experts said the cancer was rare, but men should be aware of changes. It is important to visit your GP straight away if you notice any change in your body that is not normal Henry Scowcroft, Cancer Research UK The researchers looked at a National Cancer Institute data on cancer incidence and survival in the US from 1973 to 1998. They found that, over the last 20 years, the incidence of male breast cancer had increased from 0.86 to 1.08 per 100,000 men. They then examined 2,524 cases of male breast cancer and 380,856 cases of female breast cancer on the database, diagnosed over that period. The researchers found that compared to female patients, men tended to be significantly older when they were diagnosed - 67 years versus 62 years of age.

They were also more likely to have later stage disease and had more spread of the cancer to their lymph nodes. ‘Easier to spot’ Professor Sharon Giordano, who led the research, said: “Male breast cancer is rare, accounting for less than one per cent of all breast cancer. “But she said: “Men should be alert to the possibility that the disease could affect them.” Professor Giordano added: “It’s perhaps ironic that tumours in men are easier to feel than they are in women, yet the disease is being discovered at a later stage in men than in women.” The researchers say that part of the reason for late diagnosis may be that men assume they are experiencing a benign condition called gynecomastia, or breast tissue growth, that affects about a third of males at some point in their lives.

The condition, which is common in teenage boys, can come and go over a man’s lifetime. Professor Giordano said: “Men may think new growth of breast tissue is just another occurrence of this condition.” The team also found that men often had more larger tumours which had spread further and more aggressive forms of cancer when they were diagnosed.However, survival rates for men and women were no different. The researchers said men were more likely than women to have oestrogen-positive tumours. Professor Giordano: “We are not sure why this is so, but it may indicate some important differences in tumour biology.”In addition, this implies that use of tamoxifen in men may be as beneficial as it is to many women.” She added: “Now that we have a clearer understanding of the biology of breast cancer in men, further research is needed to determine the optimal treatment for men.”

‘Campaigns aimed at women’

Henry Scowcroft, Science Information Officer at Cancer Research UK said: “Breast cancer is very rare among UK men, and when it does occur, it tends to do so between the ages of 60 and 70.”Only about 300 men are diagnosed with the disease each year, compared with about 41,000 new cases in women. Because of this, most breast cancer awareness campaigns are aimed at women. “While Cancer Research UK does not recommend that men, especially young men, examine themselves regularly, it is important to visit your GP straight away if you notice any change in your body that is not
normal.”

 

Prostate cancer research 10years behind breast cancer research

Santa Rosa Memorial Hospital has been selected to take part in what doctors said is a promising 10-year national study on whether vitamin supplements can help prevent prostate cancer, the second leading cause of death for men.

The research project is funded as part of a National Cancer Institute study that involves tracking the health of 32,000 men, some of whom will be taking supplements of Vitamin E and selenium, a sulfur-like chemical that occurs naturally in fresh produce. It will be the largest ever study of prostate cancer prevention. “This is the way we make progress against cancer,” said Tish Murphy, a nurse and research program manager.

The cancer research center is currently conducting about 60 other clinical trials involving lung, breast, colon and lymphoma cancer. However, officials say this one is intriguing because prostate cancer is regarded as one of the most preventable and treatable of all cancers. “In prostate cancer research, we are 10 years behind the level where we are today in breast cancer research,” said Dr. Wayne Keiser, an oncologist and principal investigator of program research.

After lung cancer, prostate cancer is the leading cause of death among American men. Cancer of the prostate gland, which controls the flow of urine, has been found to be more common in men over 55, in families with histories of prostate cancer, among blacks, and among heavy smokers and drinkers.

About 200,000 new cases of prostate cancer are diagnosed every year, and more than 30,000 prostate cancer deaths are reported annually. There is increasing evidence from less extensive clinical trials that Vitamin E and selenium reduce the incidence of prostate cancer. In addition, an increasing number of urologists are prescribing supplements such as Vitamin E, selenium and saw palmetto to men concerned about prostate health. The cancer research program run by Santa Rosa Memorial is looking for about 40 men to participate in the study. The cancer center advertised last October for clinical trial participants and received about 100 inquiries. However, only 11 turned out to be eligible because many were excluded for various reasons, including the fact that they were already taking the dietary supplements and did not wish to stop.

Keiser said the proliferation of health information - particularly that available over the Internet - has made it more difficult for research programs like theirs to recruit participants. Clinical trials involve long-term commitments to taking prescribed dosages, including placebos, and medical information often supersedes trial results. “Doctors and patients want to have the best possible things, but there are times that things turn out to be the opposite of what we think,” Keiser said. “The truth is that we don’t know that Vitamin E or selenium work.”

Keiser cited the example of the weight-loss supplement ephedra, which was in common use long before clinical trials deemed it to be harmful. The Memorial Hospital cancer center on Round Barn Boulevard operates about 60 clinical trials and a dozen pharmaceutical trials under contract with the Redwood Regional Medical Group. The group of 30 oncologists and radiologists perform much of the cancer treatment in Sonoma, Marin, Mendocino and Lake Counties. Ann Lowry, cancer center research coordinator, said the program intends to place new advertisements for participants and seek help from local doctors.

 

FYI: United Devices THINK - Cancer Research

In light of some recent events involving fandom members (Michael Scott McMurray, Carole Curtis), I thought this might be of interest. United Devices has released a device that works on the same principle that the SETI@Home project does - many computers with (combined) oodles of processing power working together towards a common goal. In this case, the common goal is finding a cure for cancer.

I’ve been running the client for about a month, and haven’t had any problems. It runs on idle processes while you’re at the computer, and I haven’t noticed any lag at all related to the device. I have a 300MHz processor and it runs through data packages in about 14 hours.

Right now the only module available is the THINK module, designed for cancer research. The device screens possible drug molecules against a specific cancer- causing protein to see if there are positive interactions. (Way more involved than that, I know…) In the future you’ll have a chance to switch modules to do things like genetic research or digitizing valuable, one of a kind documents.

 

Breakthrough in Cancer Research?

Knowledge gained of how a cell becomes cancerous holds hope for a cure for the deadly disease, says Professor Daniel Louvard, who directs research at the Curie Institute in Paris. Although 20 years of work has not led to a cure, scientists have learnt that there are unique patterns in the way a person develops cancer. And this, he predicts, will lead to a breakthrough involving treatments that are tailored to the individual in about a decade’s time.

Prof Louvard, 50, has been with the 75-year-old institute, which focuses on cancer research, since 1993.He granted an interview when he was in Singapore recently to deliver a public lecture at the Institute of Molecular Agrobiology on the future of cancer research. He said that, contrary to recent reports, there will be no catch-all cure for all the various types of cancer that exist.

For instance, a front-page report in the New York Times in May said a combination of two drugs, angiostatin and endostatin, might yield a cure for cancer in two years. But these drugs were soon found to be effective only in mice. He said: “There will be no magic bullet cure because each patient has his own tumour with its own identity.” The pattern in which a normal cell becomes cancerous is unique in every individual.

Therefore, he explained, an effective treatment is one that is adjusted to the cancer pattern in the patient.But current practice is to try various treatments - such as chemotherapy - and stop them if they prove futile, he said. Surgery is useful, but only to an extent, as the cancer cells could move and thus may not be removed completely in an operation.

Chemotherapy, meanwhile, is a blind approach, he said. “It is not targeted. So while you killing cancer cells, you could also kill notmal cells, and end up killing the patient.” Two new instruments that the Curie Institute is working on and bout which he is excited are in the areas of immunology and cell death.

He said: “We want to stimulate the immune system and wake it up to protect you against the disease.” Giving the advantage of this strategy, he said: “The immune system can find unhealthy cells in places drugs can’t reach, like the brain and cartilage.” The process involves extracting immune and tumour cells from the patient, stimulating the former in a test-tube so that it fights the tumour, and then injecting it back into the patient.

Cell death, or apoptosis, is another area of research that he is optimistic about. Unlike normal cells, cancerous ones do not self-destruct. “We are trying to introduce a molecule that will lead the tumour cell to kill itself.”This could either be done with drugs or through gene therapy,” he said. He reiterated repeatedly that none of these treatments could cure cancer on its own.

Instead, a combination of approaches should be used based on an understanding of the growth pattern of cancerous cells. His own 20-year battle against cancer as a researcher has sometimes felt like running up an endless uphill path, he said. But the former national long-distance runner has brought the qualities he learnt on the training field to his research. He said: “Running taught me patience, endurance and how to overcome pain - things that I need in my work.”

 

AMA Conceals Abortion-Breast Cancer Research?

The Coalition on Abortion/Breast Cancer denounces the Minnesota Medical Association (MMA), a chapter of the American Medical Association (AMA), for opposing efforts by the Minnesota Public Health Department (MPHD) to educate women about the abortion-breast cancer (ABC) research.

The MPHD published a handbook discussing the risks of abortion.  The MMA is distressed about a factual statement, “Findings from some studies suggest there is an increased risk of breast cancer among women who had an abortion, while findings from other studies suggest there is no increased risk.”  The MMA wrote to Minnesota Governor Tim Pawlenty and falsely claimed there is agreement in the medical community that abortion doesn’t increase breast cancer risk.

Coalition president Karen Malec remarked, ‘The MMA  lied to Governor Pawlenty. Truth is, five medical groups say abortion is a cause of breast cancer.  A sixth group has called for ‘full disclosure’ of a ‘highly plausible’ relationship’ an act which is an anathema to the AMA.’  [1]

Three months ago, the first American ABC lawsuit was settled.  A physician was sued for having failed to warn his patient about the risks of breast cancer and emotional harm. Stop worrying about medical malpractice insurance premiums and the loss of abortion income. Try putting people’s lives ahead of your own financial interests,’ said Mrs. Malec to the AMA.

The AMA’s priorities haven’t changed since 1964 when it accepted $10 million from tobacco companies and then opposed efforts in Congress to require tobacco companies to put warning labels on cigarette packages.

Among 16 studies on American women, 13 report risk elevations. [2]  Research published in the AMA’s journal demonstrated that relative risk increases with age at diagnosis.  [3]  In addition, a study on rats reveals that more aborted rats develop breast cancer after being exposed to a carcinogen than virgin rats and rats with pups. [4]

Estrogen overexposure is connected with the develop- ment of most breast cancers.  Women are exposed to more estrogen starting early in a viable pregnancy than at any other time in their lives. Estrogen overexposure is especially harmful to women whose breast tissue hasn’t matured into cancer-resistant Types 3 and 4 lobules, which only develop in the third trimester of pregnancy.

I have two challenges for the MMA,’ declared Mrs. Malec. ‘First, disprove the biological explanation for the ABC link.  No scientist has been able to do so.Neither will you.  Second, identify one risk factor for breast cancer, which has more evidence amassed against it than does abortion.’

The Coalition on Abortion/Breast Cancer is an inter- national women’s organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.